Connect with us

Technology

Trialbee Adds Industry Authority John Murray-Pryce to Its Distinguished Advisory Board

Published

1 week ago

on

Dr. John Murray-Pryce brings 25 years of bringing innovative new medicines to patients and creating equity in clinical research

WILMINGTON, Del. and MALMO, Sweden, Sept. 13, 2024 /PRNewswire-PRWeb/ — Trialbee, the global leader in technology-driven patient recruitment for clinical trials, is thrilled to announce the appointment of John Murray to its Advisory Board. With a distinguished career spanning key areas of drug development, John brings invaluable experience and a lifelong passion for bringing innovative therapies to market while improving the equity of clinical research access for all patients worldwide.

My decision to join the Trialbee team was an easy one. To be able to contribute directly to a fast-growing company that is transforming patient recruitment and is similarly committed to equity is extremely exciting.

John joins the Trialbee Advisory Board following nearly 20 years at AstraZeneca, where he held diverse leadership roles across Medicine Development, Clinical Supply Chain, R&D Digital Health, and most recently Digital Patient Recruitment. Prior to that, he spent five years in Technical Operations at Merck & Co. John has a strong educational background in chemical engineering and is a Visiting Lecturer at the University of Birmingham. This unique combination has provided him firsthand knowledge of what it takes to bring a drug to market – and what it takes to bring people to clinical trials.

His decision to join Trialbee is driven by three key factors:

Remarkable Global Team. In an industry devoted to connecting patients and their families to better health opportunities, it’s critical to have talented and passionate people managing your recruitment solutions. The experienced team at Trialbee has earned its reputation for white glove Precision Management and unparalleled global expertise – with meaningful internal values to be humble, kind, curious, and fun.Industry-leading Patient Recruitment Platform (PRP). The Honey Platform™ stands out for its ability to find patients from multiple sources, medically pre-qualify them, connect them seamlessly with sites, and manage their journey from interest through enrollment. He specifically notes Honey’s consumer-grade user interface and flexible integration capabilities making it such a powerful tool in the emerging PRP landscape.Swedish Culture. John’s admiration for the Swedish culture is characterized by its quality and democratic values across gender, racial, political, and all other boundaries. These cultural attributes permeate every customer engagement at Trialbee as the team collaborates with sponsors, CROs, and sites to bring more equitable access to clinical research opportunities, and eventually life-changing treatments, to all patients worldwide.

“I am passionate about equity in society,” said John. “My decision to join the Trialbee team was an easy one. To be able to contribute directly to a fast-growing company that is transforming patient recruitment and is similarly committed to equity is extremely exciting. Throughout my career at major global pharmaceutical companies, I’ve seen how impactful the right combination of technology, people and process can be. By joining at this pivotal time, I hope to offer insights and learnings that help this team thrive. I am also eager to learn from what my fellow members on this impressive board.”

John joins an Advisory Board with more than a dozen proven leaders in life sciences, headed by Craig Lipset, including representatives from Bristol Myers Squibb, AbbVie, Savvy Cooperative, Actigraph, WebMD, and many more (view full Advisory Board members).

“I’m humbled and proud to work with such wonderful people helping guide our strategy and direction as we transform the face of global patient recruitment, and we all do it because patients deserve more from clinical research,” said Matt Walz, Trialbee CEO. “John brings an incredible wealth of experience having seen so many sides of technology in drug development and primarily through the lens of major pharmaceutical companies who have the potential to make tremendous impact on health equity and access to new medicines. I’m inspired by the quality and passion of our Advisory Board and it’s only more impressive this morning with John Murray-Pryce joining the Trialbee mission to improve clinical research access for all.”

To take control of your global patient recruitment, visit www.trialbee.com.

About Trialbee

Trialbee is revolutionizing the patient recruitment ecosystem with technology, people, and passion. The company’s vendor-agnostic Honey Platform™ is a SaaS Patient Recruitment Platform that centralizes and standardizes all recruitment activities from every source, channel, and partner from interest through enrollment — providing unprecedented transparency and actionable insights for real-time patient tracking, higher-quality referrals that reduce site burden, and robust ROI reporting. Honey is surrounded by a team of Precision Recruitment experts who meet patients where they are in their journey with data-driven modeling based on consumer behavior and other real-world data, hyper-targeted digital outreach, two-step pre-qualification, and meaningful Omnichannel partners focused on meeting patients where they are in the treatment journey. To take control of patient recruitment for your next study, visit trialbee.com and follow us on LinkedIn.

Media Contact

Kristopher Sarajian, Trialbee, 46 101 963 260, kristopher.sarajian@trialbee.com, https://www.trialbee.com

View original content:https://www.prweb.com/releases/trialbee-adds-industry-authority-john-murray-pryce-to-its-distinguished-advisory-board-302247276.html

SOURCE Trialbee

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

48-Hour Saudi Visa Processing, Major Discounts and Unmissable Giveaways – Only at ‘Spectacular Saudi’ in Mumbai

Published

22 mins ago

on

September 21, 2024

By

NEW DELHI, Sept. 21, 2024 /PRNewswire/ — Saudi’s national tourism brand, ‘Saudi Welcome to Arabia’ is hosting its first-ever immersive consumer event ‘Spectacular Saudi’, from September 25 to October 2,  from 2:00 p.m. – 10:30 p.m. at R2 Ground in BKC, Mumbai.

Slated to transport visitors straight to the Heart of Arabia; the 8-day immersive experience will give visitors a glimpse into Saudi’s many wonders and iconic experiences – all while extending the warm Saudi welcome. To give consumers a truly memorable experience Saudi is offering exclusive giveaways and discounts specially curated for Indian travellers.

What’s more, Indian travellers can fast-track their Saudi visas exclusively at the event. All you need is a valid Visa or Mastercard credit card! Head on over to one of eight dedicated Tasheer kiosks, ensure the name on the credit card matches the passport, and have sufficient funds available on the card. After that, sit back and relax as your visa will be in hand within 48 hours!

It has never been easier to visit Saudi. With the most seamless visa process offered to date, the excitement doesn’t end there. On the travel front, SAUDIA Airlines is offering special deals, including a buy one get 50% off on the second ticket if travelling business class. Additionally, all economy class tickets will be 15% off. Attendees will also have the chance to participate in daily giveaways for free flight tickets for two to Saudi. With over 50+ travel trade offers, visitors can access incredible cashback and discounts on Saudi travel packages. Additionally, those booking Saudi packages will enjoy complimentary cultural city tours. Group tour packages to Riyadh, Jeddah, and Dammam will be available exclusively at the event, starting at INR 99,999 for 5 nights.

Visitors can expect unique immersive experiences–including exhibits, culinary delights, Ardah dancers, Saudi coffee, traditional scents, and fashion–all under one roof. So don’t miss out and register here to experience a piece of Saudi, right in the heart of Mumbai.

Photo – https://mma.prnewswire.com/media/2511104/Spectacular_Saudi.jpg

 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/48-hour-saudi-visa-processing-major-discounts-and-unmissable-giveaways–only-at-spectacular-saudi-in-mumbai-302254776.html

Continue Reading

Technology

Indian Cancer Genome Atlas Launches the Country’s First Comprehensive Cancer Multi-Omics Data Portal

Published

22 mins ago

on

September 21, 2024

By

Offers open access to cancer data for research

NEW DELHI, Sept. 21, 2024 /PRNewswire/ — The Indian Cancer Genome Atlas (ICGA) has launched India’s first comprehensive cancer multi-omics data portal. This pioneering platform provides open access to clinically correlated data from Indian cancer patients, aimed at transforming cancer research and treatment for Indian populations.

Historically, cancer treatments in India have been based on Western data sets. However, cancers in Indian patients can differ significantly at the molecular level. ICGA’s mission is to create Indian-specific datasets to help researchers and clinicians develop personalized treatment protocols. This new open-access portal represents a monumental step in revolutionizing cancer research, specifically for Indian patients.

The ICGA cancer multi-omics portal is the first in India to offer data that includes DNA, RNA, and protein profiles of breast cancer patients, integrated with clinical outcomes. Currently, the platform consists of data from 50 breast cancer patients, with plans to expand to over 500 patients in the coming year. This data is freely accessible to the global research community under India’s PRIDE guidelines, which promote ethical sharing and collaboration in cancer research.

Key Highlights of this portal include:

India’s First Cancer Multi-Omics Data Portal: A comprehensive resource that offers detailed multi-omics data for breast cancer patients, including genomic and proteomic information.Based on cBioPortal Platform: Derived from the internationally recognized cBioPortal, this platform ensures seamless integration with global cancer research efforts.Initial Dataset from 50 Indian Patients: Provides clinically annotated DNA, RNA, and protein profiles, along with treatment histories and patient outcomes, with an aim to scale up to 500 in a year.Free Access Under PRIDE Guidelines: Adhering to responsible and ethical data-sharing practices, the portal is freely accessible to the scientific community.A Step Toward Precision Oncology for Indian Patients: This initiative is designed to enable the development of personalized cancer treatments tailored to Indian patients.Call for Collaboration:  ICGA invites researchers worldwide to contribute and expand the platform, fostering global collaboration in cancer research.

Professor Shekhar C. Mande, Former DG-CSIR, Currently Senior Professor at Savitribai Phule Pune University
“Making this invaluable cancer data publicly accessible marks a pivotal step in accelerating scientific discoveries and enhancing patient outcomes. By openly sharing this data, we are empowering researchers, clinicians, and innovators to collaborate, explore new frontiers, and drive transformative breakthroughs in cancer treatment.”

Joint Statement from Dr JC Zenklusen – Director of The Cancer Genome Atlas (TCGA) at the NCI, NIH, USA, and Prof Sunil Badve – Vice Chair, Pathology Cancer Programs, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
“Fifteen years ago, when we launched TCGA, we could not have foreseen the remarkable progress cancer research would make. It is incredibly exciting to see ICGA advancing so rapidly and taking bold steps in revolutionizing cancer research. Understanding the genome of cancer patients will improve the treatment of Indians not only in India but also worldwide. We, both, encourage others with similar data to actively contribute to ICGA, so this initiative can grow even faster and drive greater breakthroughs.”

Dr. Anand Deshpande, Chairman and Managing Director at Persistent, and Non-Executive Director at ICGA
“We have made an excellent start with this groundbreaking multi-omics cancer portal. Cancer touches all of us, and the need for more effective, personalized treatments—especially tailored to the unique genetic and environmental factors in India—is urgent. This portal will empower researchers with crucial data to advance customized cancer research for better treatment outcomes. I encourage everyone to contribute and support this vital cause, helping us accelerate progress in the fight against cancer.”

About Indian Cancer Genome Atlas (ICGA):
The Indian Cancer Genome Atlas (ICGA) is a national initiative focused on mapping the genomic, transcriptomic, and proteomic landscapes of cancers across India. As a section 8 not-for-profit organization, the ICGA Foundation, operates through a public-private-philanthropic partnership, with active support from over 50 clinicians, researchers, and data analysts. Its mission is to enhance cancer diagnosis and treatment for Indian patients and contribute to the global understanding of cancer biology. The foundation’s first project focuses on the multi-omics profiling of breast cancer, with plans to extend this effort to other types of cancer in the future.

https://www.icga.in/

View original content:https://www.prnewswire.com/in/news-releases/indian-cancer-genome-atlas-launches-the-countrys-first-comprehensive-cancer-multi-omics-data-portal-302254777.html

Continue Reading

Technology

Huawei Launches All-New Xinghe Intelligent Campus with Full Upgrades, Maximizing Enterprises’ Intelligent Productivity

Published

1 hour ago

on

September 21, 2024

By

SHANGHAI, Sept. 21, 2024 /PRNewswire/ — During HUAWEI CONNECT 2024, the Xinghe Intelligent Campus session was successfully held, attracting more than 200 industry pioneers, experts, and scholars from around the world to explore campus network trends and technological innovations. Also at the event, Huawei unveiled its all-new Xinghe Intelligent Campus Solution that stands out for full upgrades to wireless, application, and operations & maintenance (O&M) experience.

Shawn Zhao, President of the Campus Network Domain, Huawei’s Data Communication Product Line, said, “As video conferencing, AI terminals, and AI applications become more widespread, the campus network access density has increased threefold, and the demand for bandwidth has grown tenfold. In this case, users place new requirements on the assurance for AI applications and audio/video services while expecting more intelligent O&M.”

To meet these needs, Huawei launched its all-new Xinghe Intelligent Campus Solution with full upgrades. Specifically, this solution upgrades wireless experience in performance, roaming, and IoT convergence. It also leverages X-Scheduler (an experience scheduling engine) to upgrade application experience, while drawing on AI-assisted decision-making and a tidal prediction algorithm to upgrade O&M experience. These help customers build an industry-leading digital infrastructure and facilitate the digital and intelligent transformation of enterprises.

In addition, the solution provides end-to-end security assurance. On the wireless side, the innovative Wi-Fi Shield technology radically prevents packet eavesdropping on the air interface. On the wired side, the full-link MACsec capabilities from switches to APs ensure secure campus network data transmission since the very beginning.

Also at the session, leading analyst firms, customers, and partners in various industries shared their unique insights, best practices, and successful cases. Key speakers include Sian Morgan, Research Director of Dell’Oro Group; Dr. Haitham S. Hamsa, Professor of Information Technology, Cairo University; Shang Qun, Assistant to the Director of the Computing Center, Peking University; Sun Pan, Director of Infrastructure Operations Dept, System Digitalization Dept, FAW Group; Connee Zhang, CEO of CypressTel. Their valuable practices will provide a unique reference for the digital and intelligent transformation of enterprises across industries.

Looking ahead, Huawei believes that the Xinghe Intelligent Campus Solution will become the preferred choice for global enterprises’ digital and intelligent transformation to reap more benefits.

For more information about Huawei’s Xinghe Intelligent Campus Solution, visit https://e.huawei.com/en/solutions/enterprise-network/campus-network.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/huawei-launches-all-new-xinghe-intelligent-campus-with-full-upgrades-maximizing-enterprises-intelligent-productivity-302254770.html

SOURCE Huawei

Continue Reading

Trending